Indication
Cervical Squamous Cell Carcinoma In Situ
3 clinical trials
6 products
1 drug
Clinical trial
A Phase II Open-Label, Single Arm Pilot Study to Evaluate the Safety and Efficacy of Pembrolizumab for High-Grade Cervical Intraepithelial NeoplasiaStatus: Recruiting, Estimated PCD: 2025-01-31
Product
PembrolizumabClinical trial
A Feasibility Trial of Alternating Intravaginal Application of 5-Fluorouracil and Imiquimod for Treatment of High-Grade Cervical Squamous Intraepithelial LesionsStatus: Active (not recruiting), Estimated PCD: 2020-11-04
Product
ImiquimodProduct
Topical FluorouracilClinical trial
A Two-Cohort Randomized Phase 2 Trial of the IRX-2 Regimen in Women With Squamous Cervical Intraepithelial Neoplasia 3 (CIN 3) or Vulvar Intraepithelial Neoplasia 3 (VIN 3)Status: Active (not recruiting), Estimated PCD: 2024-11-08
Drug
cyclophosphamideProduct
IndomethacinProduct
IRX-2Product
Omeprazole